Purchase Order 75N91020P00894

The National Cancer Institute awarded a $42,941.42 delivery order to Alchem Laboratories Corporation for the non-Good Manufacturing Practice (non-GMP) synthesis of 100 grams of (R)-N-(6-chloro-4-((1-phenylethyl)amino)pyrido[3,4-d]pyrimidin-5-yl)methanesulfonamide (MTX-531), a small molecule compound. The contract was awarded on July 22, 2022, with an ultimate completion date of October 21, 2022, under a cost-plus-fixed-fee pricing structure. This award was designated as a Total Small Business...

The National Institute on Drug Abuse issued a purchase order to Cyprotex US LLC on September 12, 2022, with a ceiling value of $28,052.00 for testing of compounds in cytochrome P450 inhibition, HERG inhibition, plasma protein binding, and Caco-2 permeability assays as part of the FY26 UDO Initiative. Performance occurs in Watertown, Massachusetts. The order is firm fixed price with an ultimate completion date of January 31, 2023. The requirement originated from a pre-solicitation opportunity...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Xcopri 200 mg tablets (30-count), with a ceiling value of $1,712.07.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion by February 6, 2026, and is priced on a firm fixed-price basis. The delivery order was issued under a non-set-aside competitive vehicle.</p>

This firm fixed-price purchase order for $30,778.40 was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Discoverx Products, LLC. The contract is to provide one PathHunter detection kit (PN 93-0001XL) to support NCATS' high-throughput screening efforts for GPR151, a target related to pain and addiction under the NIH HEAL (Helping to End Addiction Long-term) Initiative. Eurofins Discoverx Products was...

<p>The Defense Logistics Agency issued a $1,712.07 delivery order to Amerisourcebergen Drug Corp on March 13, 2026, for Xcopri 50 mg tablets (30 tablets) with a firm fixed price and ultimate completion date of March 16, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued under a non-competitive, non-set-aside basis.</p>

This is a task order award to Bachem Americas Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for a 3-year stability study extension on a cGMP batch of the drug substance leucine enkephalin (L-ENK). The $56,100.00 firm fixed-price award was made by the National Institute on Drug Abuse, a civilian agency within the Department of Health and Human Services. The task order is part of a larger $49,713,679.00 Indefinite Delivery/Indefinite Quantity (IDIQ) contract held by Bachem...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Acamprosate Calcium 333 mg tablets (180-count) with a ceiling value of $1,687.20. This non-set-aside, competitively awarded contract was executed on December 10, 2025, with an ultimate completion date of December 11, 2025, under a firm fixed-price arrangement. The drug will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....

The National Institute on Drug Abuse issued a $131,900 delivery order to Mriglobal (doing business as Midwest Research Institute) on June 3, 2022, under the CRO Support for NCATS Drug Substance Development and Manufacture contract for stability studies on ML-246 (METARRESTIN) and contract research organization support for drug substance development and manufacture. Place of performance is Kansas City, MO. The order is firm fixed price with an ultimate completion date of January 30, 2028. No...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xcopri 150 mg tablets (30-count) with a ceiling value of $2,343.30 under a firm fixed-price contract type. The award was issued on October 30, 2025, with an ultimate completion date of October 31, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for TAGRISSO 80 mg tablets (30-count), with a ceiling value of $24,876.30 and an ultimate completion date of March 16, 2026.</p> <p>Place of performance is Conshohocken, PA 19428. The order is issued under firm fixed-price pricing with no set-aside applied.</p>